Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma

Published:2021-10 Issue: Volume:338 Page:211-223
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Phung Cao Dai,Tran Tuan Hiep,Nguyen Hanh Thuy,Nguyen Tien Tiep,Jeong Jee-Heon,Ku Sae Kwang,Yong Chul Soon,Choi Han-Gon,Kim Jong Oh

Funder

Ministry of Science, ICT and Future Planning

NRF

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference72 articles.

1. Nanoparticles for dendritic cell-based immunotherapy;Tran;Int. J. Pharm.,2018

2. Dendritic cell subsets in T cell programming: location dictates function;Eisenbarth;Nat. Rev. Immunol.,2019

3. Rational combination immunotherapeutic approaches for effective cancer treatment;Phung;J. Control. Release,2019

4. Biomaterials for vaccine-based cancer immunotherapy;Zhang;J. Control. Release,2018

5. Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine;Tateshita;J. Control. Release,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens;Journal of Controlled Release;2024-09

2. Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy;Cell Proliferation;2024-03-20

3. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy;Journal of Controlled Release;2024-01

4. Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment;Journal of Controlled Release;2023-09

5. Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell;Advanced Science;2023-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3